EKG monitoring of patients on citalopram after the 2011 FDA safety announcement
LB Gerlach, K Zivin, J Kavanagh, C Stano… - The American Journal of …, 2014 - Elsevier
Methods A retrospective chart review was performed by a pharmacist team to determine the
daily dose of citalopram for all adult patients with an active prescription. Patients were
identified through primary care clinics throughout the University of Michigan Healthcare
system after the FDA safety announcement in 2011. Patients receiving doses above the
recommended limit (> 40 mg daily or> 20 mg in adults> 60 years old, hepatic impairment, or
on other medications that inhibit citalopram metabolism) or considered at risk for QTc …
daily dose of citalopram for all adult patients with an active prescription. Patients were
identified through primary care clinics throughout the University of Michigan Healthcare
system after the FDA safety announcement in 2011. Patients receiving doses above the
recommended limit (> 40 mg daily or> 20 mg in adults> 60 years old, hepatic impairment, or
on other medications that inhibit citalopram metabolism) or considered at risk for QTc …
以上显示的是最相近的搜索结果。 查看全部搜索结果